| Autor: |
Jia Z; NUSNNI-Nanocore, National University of Singapore, Singapore 117411, Singapore., Thavasi V; Center for Quantum Research and Technology, Homer L. Dodge Department of Physics and Astronomy, University of Oklahoma, Norman, OK 73019, USA., Venkatesan T; NUSNNI-Nanocore, National University of Singapore, Singapore 117411, Singapore.; Center for Quantum Research and Technology, Homer L. Dodge Department of Physics and Astronomy, University of Oklahoma, Norman, OK 73019, USA., Lee P; Respiratory and Critical Care Medicine, National University Hospital, 1E Kent Ridge Road, Singapore 119228, Singapore. |
| Jazyk: |
angličtina |
| Zdroj: |
Metabolites [Metabolites] 2023 Dec 12; Vol. 13 (12). Date of Electronic Publication: 2023 Dec 12. |
| DOI: |
10.3390/metabo13121197 |
| Abstrakt: |
This clinical study presents a comprehensive investigation into the utility of breath analysis as a non-invasive method for the early detection of lung cancer. The study enrolled 14 lung cancer patients, 14 non-lung cancer controls with diverse medical conditions, and 3 tuberculosis (TB) patients for biomarker discovery. Matching criteria including age, gender, smoking history, and comorbidities were strictly followed to ensure reliable comparisons. A systematic breath sampling protocol utilizing a BIO-VOC sampler was employed, followed by VOC analysis using Thermal Desorption-Gas Chromatography-Mass Spectrometry (TD-GC/MS). The resulting VOC profiles were subjected to stringent statistical analysis, including Orthogonal Projections to Latent Structures-Discriminant Analysis (OPLS-DA), Kruskal-Wallis test, and Receiver Operating Characteristic (ROC) analysis. Notably, 13 VOCs exhibited statistically significant differences between lung cancer patients and controls. The combination of eight VOCs (hexanal, heptanal, octanal, benzaldehyde, undecane, phenylacetaldehyde, decanal, and benzoic acid) demonstrated substantial discriminatory power with an area under the curve (AUC) of 0.85, a sensitivity of 82%, and a specificity of 76% in the discovery set. Validation in an independent cohort yielded an AUC of 0.78, a sensitivity of 78%, and a specificity of 64%. Further analysis revealed that elevated aldehyde levels in lung cancer patients' breath could be attributed to overactivated Alcohol Dehydrogenase (ADH) pathways in cancerous tissues. Addressing methodological challenges, this study employed a matching of physiological and pathological confounders, controlled room air samples, and standardized breath sampling techniques. Despite the limitations, this study's findings emphasize the potential of breath analysis as a diagnostic tool for lung cancer and suggest its utility in differentiating tuberculosis from lung cancer. However, further research and validation are warranted for the translation of these findings into clinical practice. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
